Abstract
n engl j med 373;18 nejm.org october 29, 2015 1786 was a similar trend favoring patency in patients who received statins. Also, treatment with a drugcoated balloon was associated with improved patency over a conventional balloon in both patients receiving statins and those not receiving statins. The beneficial effects of statins may be additive to those of drug-coated balloons. In summary, our trial showed that angioplasty with a drug-coated balloon maintained vessel patency that was superior to that of angioplasty with a standard balloon, and it showed superiority for a functional end point on the Walking Impairment Questionnaire. We agree that all patients should receive maximum tolerated doses of statins and that data from larger studies are lacking to confirm the beneficial effects on quality of life and physical functioning conferred by angioplasty with a drug-coated balloon over conventional angioplasty with a standard balloon.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
